Moreover, Rab10 pT73 levels in urine exhibited a positive association with PD disease progression [142], suggesting that this could represent a valid target engagement biomarker for LRRK2 inhibitors in the clinic [143]. Here, LRRK2 is linked to Parkinson disease.